| Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population (NCT05176249) | Ann & Robert H Lurie Children's Hospital of Chicago | 2011-10-01 |
| Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis (NCT01386112) | Forest Laboratories | 2011-09-01 |
| Improved Diagnostics of Celiac Disease in Children (NCT02072590) | Tampere University Hospital | 2011-08-01 |
| Risk Factors and Biomarkers for Diagnosis and Treatment of EoE (NCT01988285) | University of North Carolina, Chapel Hill | 2011-07-28 |
| A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis (NCT05176262) | Ann & Robert H Lurie Children's Hospital of Chicago | 2011-07-01 |
| Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis (NCT02280616) | Dr. Falk Pharma GmbH | 2011-06-01 |
| Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis (NCT01631591) | University of South Florida | 2011-05-01 |
| Eosinophilic Esophagitis Databank (NCT01323803) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis (NCT03822325) | Ann & Robert H Lurie Children's Hospital of Chicago | 2011-02-01 |
| Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease (NCT02190513) | St. John Health System, Michigan | 2011-02-01 |
| Molecular Basis of Food Allergy (NCT01832324) | Children's Hospital of Philadelphia | 2011-01-01 |
| Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis (NCT01234376) | University of Erlangen-Nürnberg Medical School | 2010-11-01 |
| Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders (NCT01212016) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-30 |
| Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis (NCT01170234) | Tufts Medical Center | 2010-08-01 |
| Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies (NCT02038894) | Children's Hospital Medical Center, Cincinnati | 2009-12-01 |
| Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis (NCT01022970) | Novartis Pharmaceuticals | 2009-11-01 |
| Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model (NCT01040598) | O & O Alpan LLC | 2009-06-01 |
| Esophageal String Test in Eosinophilic Esophagitis (NCT02008903) | University of Colorado, Denver | 2009-01-01 |
| Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis (NCT00635089) | Ception Therapeutics | 2008-07-01 |
| The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis (NCT00728481) | Mayo Clinic | 2008-05-01 |
| Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis (NCT00895817) | Walter Reed Army Medical Center | 2008-04-01 |
| Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years (NCT00538434) | Ception Therapeutics | 2008-03-01 |
| Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis (NCT00638456) | Ranjan Dohil | 2008-02-01 |
| Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation (NCT00667524) | University of Bern | 2008-02-01 |
| Trial of Montelukast in Eosinophilic Esophagitis (NCT00511316) | Mayo Clinic | 2007-08-01 |
| A Study of Flovent in Patients With Eosinophilic Esophagitis (NCT00426283) | Marc Rothenberg, MD | 2007-01-01 |
| Budesonide for Eosinophilic Esophagitis (NCT00271349) | Swiss EE Study Group | 2005-12-01 |
| Topical Steroid Treatment for Eosinophilic Esophagitis (NCT00275561) | Mayo Clinic | 2005-11-01 |
| A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders (NCT00266578) | Marc Rothenberg | 2002-10-01 |
| Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome (NCT00266565) | Children's Hospital Medical Center, Cincinnati | 2001-12-01 |
| Data Bank for Eosinophilic Disorders (NCT00267475) | Marc Rothenberg | 2001-05-01 |
| Expanded Access Protocol for Patients With Eosinophilic Esophagitis (NCT05095116) | Ellodi Pharmaceuticals, LP | |
| Allergy Immunotherapy in the Management of Eosinophilic Esophagitis (NCT01685034) | United States Naval Medical Center, San Diego | |